Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maintain Biotech is a biotechnology company based in Shenzhen, China, specializing in green biocatalysis and enzymatic synthesis technology. The company develops and manufactures high-value coenzymes such as NAD, NADH, NMN, and NR, alongside various pharmaceutical intermediates and peptides including Tirzepatide and Retatrutide. Their core technology platform utilizes enzyme library screening, directed evolution, and high-density fermentation to provide non-toxic, chemical-solvent-free manufacturing processes. Maintain Biotech serves as a critical supplier and contract development and manufacturing organization (CDMO) for the global pharmaceutical, dietary supplement, and cosmetic industries. By employing aqueous reaction systems, the company offers sustainable, eco-friendly alternatives for the production of active biological ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maintain Biotech.